A. Pério

1.2k total citations
17 papers, 884 citations indexed

About

A. Pério is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, A. Pério has authored 17 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 5 papers in Pharmacology and 5 papers in Cognitive Neuroscience. Recurrent topics in A. Pério's work include Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Memory and Neural Mechanisms (5 papers). A. Pério is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Memory and Neural Mechanisms (5 papers). A. Pério collaborates with scholars based in France and Mexico. A. Pério's co-authors include Robert Dantzer, Philippe Soubrié, Jean-Paul Terranova, G. Le Fur, M Rinaldi-Carmona, P. Worms, Kathleen Bizière, Jeanne Maruani, Rose-Marie Bluthé and Francis Barth and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

A. Pério

17 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Pério France 13 601 466 283 134 125 17 884
Harvey J. Altman United States 21 791 1.3× 215 0.5× 566 2.0× 322 2.4× 161 1.3× 39 1.3k
H J Sekerke United States 8 426 0.7× 307 0.7× 263 0.9× 379 2.8× 62 0.5× 9 1.1k
Mercè Amargós‐Bosch Spain 9 818 1.4× 282 0.6× 226 0.8× 343 2.6× 96 0.8× 10 1.1k
Jean-Paul Terranova France 17 987 1.6× 554 1.2× 339 1.2× 631 4.7× 182 1.5× 20 1.4k
Ouissame Mnie‐Filali France 18 747 1.2× 241 0.5× 209 0.7× 413 3.1× 101 0.8× 31 1.1k
DavidS. Janowsky United States 5 351 0.6× 260 0.6× 235 0.8× 312 2.3× 60 0.5× 6 974
L.A. Riblet United States 15 709 1.2× 161 0.3× 196 0.7× 356 2.7× 116 0.9× 22 1.1k
Showa Ueki Japan 14 555 0.9× 174 0.4× 238 0.8× 262 2.0× 89 0.7× 96 931
Tom J. Kornecook Canada 12 438 0.7× 247 0.5× 340 1.2× 259 1.9× 52 0.4× 13 1.0k
Minna Riekkinen Finland 24 800 1.3× 252 0.5× 621 2.2× 468 3.5× 54 0.4× 57 1.2k

Countries citing papers authored by A. Pério

Since Specialization
Citations

This map shows the geographic impact of A. Pério's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Pério with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Pério more than expected).

Fields of papers citing papers by A. Pério

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Pério. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Pério. The network helps show where A. Pério may publish in the future.

Co-authorship network of co-authors of A. Pério

This figure shows the co-authorship network connecting the top 25 collaborators of A. Pério. A scholar is included among the top collaborators of A. Pério based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Pério. A. Pério is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rinaldi‐Carmona, Murielle, Francis Barth, Christian Congy, et al.. (2004). SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1 H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization. Journal of Pharmacology and Experimental Therapeutics. 310(3). 905–914. 103 indexed citations
2.
Pério, A., et al.. (2001). Activity of SH141716 on post-reinforcement pauses in operant responding for sucrose reward in rats. Behavioural Pharmacology. 12(8). 641–645. 23 indexed citations
3.
Pério, A., M Rinaldi-Carmona, Jeanne Maruani, et al.. (1996). Central mediation of the cannabinoid cue. Behavioural Pharmacology. 7(1). 65???71–65???71. 58 indexed citations
4.
Terranova, Jean-Paul, et al.. (1996). Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology. 126(2). 165–172. 239 indexed citations
5.
Pério, A., et al.. (1996). PHARMACOLOGICAL ANALYSIS OF THE EFFECTS OF BENZODIAZEPINES ON PUNISHED SCHEDULE-INDUCED POLYDIPSIA. Behavioural Pharmacology. 7(Supplement 1). 83–83. 21 indexed citations
6.
Terranova, Jean-Paul, et al.. (1994). Social olfactory recognition in rodents. Behavioural Pharmacology. 5(1). 90–98. 49 indexed citations
7.
Pério, A., et al.. (1994). Social olfactory recognition in rodents: deterioration with age, cerebral ischaemia and septal lesion.. PubMed. 5(1). 90–98. 52 indexed citations
8.
Pério, A., Jean-Paul Terranova, P. Worms, et al.. (1989). Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants. Psychopharmacology. 97(2). 262–268. 109 indexed citations
9.
Worms, P., et al.. (1989). Cholinomimetic activities of minaprine. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(4). 411–418. 30 indexed citations
10.
Jung, M., A. Pério, P. Worms, & Philippe Soubrié. (1988). Pharmacological characterization of the physostigmine stimulus in rats. Psychopharmacology. 95(4). 553–5. 9 indexed citations
11.
Jung, M., A. Pério, P. Worms, & Kathleen Bizière. (1988). Characterization of the scopolamine stimulus in rats. Psychopharmacology. 95(2). 195–9. 10 indexed citations
12.
Jung, M., A. Pério, Jean-Paul Terranova, P. Worms, & Kathleen Bizière. (1987). Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats. European Journal of Pharmacology. 139(1). 111–116. 8 indexed citations
13.
Bizière, Kathleen, Jean‐Jacques Bourguignon, J. P. Chambón, et al.. (1987). A 7‐phenyl substituted triazolopyridazine has inverse agonist activity at the benzodiazepine receptor site. British Journal of Pharmacology. 90(1). 183–190. 10 indexed citations
14.
Pério, A., et al.. (1986). Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.. Journal of Pharmacology and Experimental Therapeutics. 239(2). 542–547. 13 indexed citations
15.
Chambón, J. P., et al.. (1985). Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities.. PubMed. 35(10). 1573–7. 12 indexed citations
16.
Mormède, Pierre, Robert Dantzer, & A. Pério. (1984). Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by ro 15–1788. Pharmacology Biochemistry and Behavior. 21(6). 839–843. 20 indexed citations
17.
Dantzer, Robert & A. Pério. (1982). Behavioural evidence for partial agonist properties of RO 15-1788, a benzodiazepine receptor antagonist. European Journal of Pharmacology. 81(4). 655–658. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026